Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Naren Vyavahare
AddedMar 31, 2024
UpdatedMay 31, 2026
Naren Vyavahare

Naren Vyavahare

Co-Founder, Annoviant

CrunchbaseLinkedIn

Naren Vyavahare's Career

Annoviant
Annoviant

Alpharetta, GA, US

Co-Founder
Elastrin Therapeutics
Elastrin Therapeutics

Simpsonville, SC, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Naren Vyavahare's Career

Annoviant
Annoviant
Seed$1.9M302018Alpharetta, GA, US
Co-Founder

Leadership at Annoviant

Ajay HoudeAjay HoudeCo-Founder

Similar to Annoviant

Intact MedicalIntact MedicalFramingham, MA, USMedical Devicesest. 2002Intact MedicalFramingham, MA, US · est. 2002

US-based Intact Medical Corp. develops minimally invasive systems.

Pre-Seed · $25.7M7
Advanced Medical Device TechnologiesAdvanced Medical Device TechnologiesNewport Beach, CA, USMedical Devicesest. 2019Advanced Medical Device TechnologiesNewport Beach, CA, US · est. 2019

Advanced Medical Device Technologies: Your trusted provider of innovative medical device designs.

Seed · $250k2
AnunciaAnunciaScottsdale, AZ, USMedical Devicesest. 2018AnunciaScottsdale, AZ, US · est. 2018

Anuncia Medical: A CSF Management startup innovating to prevent shunt failure and brain surgery.

Seed · $1k35
Digital Medical TechDigital Medical TechLos Angeles, CA, USDevice Trackingest. 2016Digital Medical TechLos Angeles, CA, US · est. 2016

Digital Medical Tech: Streamlining healthcare with proactive, Bluetooth-enabled medical device tracking.

Seed · $1.5M3
Elastrin Therapeutics
Elastrin Therapeutics
Series A$20.8M52017Simpsonville, SC, US
Co-Founder

Leadership at Elastrin Therapeutics

Matthias BreugelmansMatthias BreugelmansCEO
Douglas MulhallDouglas MulhallCo-Founder
Patrick BurgermeisterPatrick BurgermeisterBoard Member
Pedro M. Quintana DiezPedro M. Quintana DiezBoard Member

Similar to Elastrin Therapeutics

TruElastin LaboratoriesTruElastin LaboratoriesChatham Borough, NJ, USMedical Devicesest. 2010TruElastin LaboratoriesChatham Borough, NJ, US · est. 2010

NJ-based biotech firm, TruElastin, pioneers in producing natural elastin biomaterials and innovative medical devices since 2010.

Pre-Seed · $1.5M3
Elgia TherapeuticsElgia TherapeuticsSan Diego, CA, USPharmaceuticals, Therapeuticsest. 2019Elgia TherapeuticsSan Diego, CA, US · est. 2019

Elgia Therapeutics: Innovating biopharma solutions for chronic inflammatory and fibrotic diseases.

Seed · $2.3M7
Eliaz TherapeuticsEliaz TherapeuticsSanta Rosa, CA, USMedical Devicesest. 2015Eliaz TherapeuticsSanta Rosa, CA, US · est. 2015

Eliaz Therapeutics: Innovating cardiovascular disease treatment via targeted therapeutic apheresis.

Seed · $1.7M5
Pliant TherapeuticsPliant TherapeuticsSouth San Francisco, CA, USTherapeuticsest. 2015Pliant TherapeuticsSouth San Francisco, CA, US · est. 2015

Pliant Therapeutics: A California-based biopharmaceutical company innovating therapies for fibrotic diseases.

Public · $694.9M124

Naren Vyavahare's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Naren Vyavahare

Steve SchwartzSteve SchwartzCo-Founder · GenomenonTed TarasowTed TarasowCo-Founder · Vanquish OncologyYael KarovYael KarovFounder · Ginger SoftwareKarthik VaidyanathanKarthik VaidyanathanCo-Founder · BankSightEmily Rains ChangEmily Rains ChangCo-Founder · TapGenesJay WestJay WestCo-Founder · BioSkryb Genomics